Michael Murphy, M.Sc., Conatus Consulting, LLC - Testimony
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0034     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Elaine Lyon, PhD, FACMG, Association for Molecular Pathology - Testimony
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0035     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Pan American Society for Clinical Virology (PASCV) - Comment
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0036     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Mitchell J. Nelles, PhD, xDx - Testimony
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0037     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Anna Longwell, Longwell and Associates - Testimony
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0038     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Genomic Health - Testimony
Posted : 07/28/2010     ID ：FDA-2010-N-0274-0039     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

William Clarke, American Association for Clinical Chemistry (AACC) - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0040     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Liz Lison, Advocea, LLC - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0041     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Klaus Schafer, TessArae LLC - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0042     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Frank Cockerill, Mayo Clinic - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0043     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Paula Revell, American Society for Microbiology - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0044     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Pheobe Mounts, Morgan Lewis - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0045     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Michael P Ryan, New York State Department of Health, Wadsworth Center - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0046     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

American Society for Clinical Laboratory Science (ASCLS) - Comment
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0047     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Bruce H. Davis, MD, Trillium Diagnostics, LLC - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0048     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Patrick Terry, European Personalized Medicine Coalition - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0049     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Gail Vance, College of American Pathologists - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0050     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Shashikant Kulkarni, Washington University School of Medicine - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0051     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Ted Snelgrove, Crescendo Bioscience - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0052     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Kathleen W. Rao, PhD, American College of Medical Genetics - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0053     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Georgirene D. Vladutiu, Ph.D., Kaleida Health Laboratories - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0054     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

John E. Tomaszewski, MD, FASCP, American Society for Clinical Pathology (ASCP) - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0055     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Bernard Sixt, Agendia - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0056     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Gualberto Ruaño, M.D., Ph.D., Hartford Hospital - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0057     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Robert A. Middleberg, Ph.D., NMS Labs - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0058     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Council for Responsible Genetics - Comment
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0059     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Destry Sulkes, Medivo, Inc. - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0060     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Association for Molecular Pathology (AMP) - Comment
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0061     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Navigenics - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0062     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET

Kenneth Emancipator, American Society for Clinical Pathology (ASCP) - Testimony
Posted : 08/06/2010     ID ：FDA-2010-N-0274-0063     Agency : FDA

Comment Period Closed
Aug 15,2010 11:59 PM ET